Expert view: Bio-Rad’s comprehensive genomics portfolio provides answers for every problem
Posted: 17 September 2019 | Bio-Rad Laboratories | No comments yet
Over three decades, Bio-Rad has built a broad genomics portfolio that touches on nearly every area of life science.
With a myriad of genomics platforms, from traditional polymerase chain reaction (PCR) and quantitative real-time PCR (qPCR) to Droplet Digital™ PCR (ddPCR), along with a broad assortment of reagents and consumables, Bio-Rad has been delivering robust, differentiated solutions for years; helping to answer complex scientific questions, advance discovery and improve health.
Related topics
Genomics, Real-time polymerase chain reaction (qPCR)
Related organisations
Bio-Rad Laboratories
